Pfizer reports positive Phase 3 results for ELREXFIO in multiple myeloma
ELREXFIO met its primary endpoint of progression-free survival versus standard regimens. Pfizer plans regulatory submissions and further clinical development.
Latest Pfizer News & Updates
See the latest news and media coverage for Pfizer. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company
pfizer.com- Headquarters
- New York, United States
- Company type
- Public company
- Number of employees
- 100,000+
- Industry
- Pharmaceuticals
Last updated
Latest news about Pfizer
In short: Pfizer reported clinical and regulatory wins while navigating lawsuits, layoffs, and pricing pressures.
Company announcements
Pfizer receives FDA approval for TALZENNA plus XTANDI
The combination treats earlier metastatic prostate cancer with HRR gene mutations. Approval is based on Phase 3 data showing a 52% risk reduction in disease progression or death.
Pfizer reports Q3 2026 corporate performance metrics
The webcast event is scheduled for November 3, 2026 at 10:00 AM ET to present quarterly results.
Pfizer invites public to Q3 conference call
The webcast occurs November 3, 2026, updating analysts on third quarter results via the company website or phone.
Media coverage
Pfizer heads to FDA with phase 3 myeloma win for Elrexfio
Pfizer's Elrexfio has taken another step on its path to potential commercial momentum: The drugmaker just announced another phase 3 win for the bispecific antibody...
Pfizer's Talzenna combo moves up treatment line with new FDA nod in prostate cancer
Pfizer's Talzenna is now the first PARP inhibitor approved by the FDA to treat men with metastatic hormone-sensitive prostate cancer (mHSPC). | Pfizer's Talzenna is...
Pfizer layoffs hit North Carolina plants as part of multibillion-dollar cost-saving measures
All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement (updated August 13, 2024) and Privacy...
Exclusive: Pfizer executive's role in FDA commissioner's rise stirs concerns
Scott Gottlieb, the Food and Drug Administration commissioner turned Pfizer director and prominent critic of Robert Kennedy Jr., has been a key ally of incoming...
Never miss news about Pfizer
Track Pfizer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Pfizer competitors & trending companies
Browse news for competitors to Pfizer and other trending companies.